Skip to main content
. 2022 Mar 22;11(3):195–200. doi: 10.1055/s-0042-1742595

Fig. 3.

Fig. 3

Survival comparison among retroperitoneal lymph node metastasis (RLNM) and distant metastasis (DM) groups who received palliative chemotherapy.